Amedica and K2M Ink Distribution Deal in Europe Amedica Corp. has signed a distribution deal with

Amedica and K2M Ink Distribution Deal in Europe
Amedica Corp. has signed a distribution deal with K2M Inc. that will provide surgeons and hospitals in Europe with access to Amedica’s interbody spinal fusion devices made with silicon nitride.

Earlier this year, Amedica and K2M conducted a successful pilot program in select markets in Europe where surgeons were provided the opportunity to integrate silicon nitride interbody devices into their offerings for patients suffering from a variety of disorders requiring spinal fusion. The companies claim the program demonstrated a need in these markets for spinal fusion devices devised from a different biomaterial.

“We are thrilled to make Amedica’s silicon nitride interbody spinal fusion devices part of our international product portfolio,” said Eric Major, K2M’s president and CEO.

“Our silicon nitride interbody product line will be integrated into K2M’s current portfolio of interbody spinal fusion devices,” said Eric K. Olson, president and CEO, Amedica. “We believe there is a need in Europe for interbody fusion devices that exceed the capabilities of existing PEEK and titanium-based devices. With this distribution channel in place, we believe silicon nitride interbody spinal fusion devices will increasingly be the solution that surgeons rely on.”

Salt Lake City, Utah-based Amedica is a biomaterial company that uses its silicon nitride technology platform to develop and sell a broad range of medical devices. Amedica markets spinal fusion products and is developing products for use in total hip and knee joint replacements.

K2M claims to be the largest privately held spinal device company in the world. The company makes technology to treat deformities, degenerative disorders, trauma injuries, and spinal tumors. K2M’s product development pipeline includes spinal stabilization systems, minimally invasive systems, biologics, and other technologies, such as motion preservation, annular repair and nucleus replacement.